MarketsStocksAUROPHARMA
AU

Aurobindo Pharma

NSE: AUROPHARMABSE: 524804Pharma
1,426.40
-0.66%
NSE · 15-min delayed
Prev Close
₹1,143.80
Day High
₹1,458.00
Day Low
₹1,419.20
Mkt Cap
₹82,845 Cr
P / E
23.6
P / B
2.2
ROE
9.2%
52W High
₹1,550.00
52W Low
₹1,016.10
Key Metrics
Market Cap
₹82,845 Cr
P / E
23.6
P / B
2.2
ROCE
12.1%
ROE
9.2%
Div Yield
0.3%
Revenue · ₹ Cr
23k
FY20
25k
FY21
23k
FY22
25k
FY23
29k
FY24
32k
FY25
34k
FY26
Net Profit · ₹ Cr
3k
FY20
5k
FY21
3k
FY22
2k
FY23
3k
FY24
3k
FY25
4k
FY26
EPS · ₹ per share
₹48.3
FY20
₹91.0
FY21
₹45.2
FY22
₹32.9
FY23
₹54.2
FY24
₹59.8
FY25
₹60.3
FY26
P / E Ratio · price ÷ TTM EPS
5132129336698Jun 21Jan 23Oct 24Jun 26
P/E 23.9×Median 19.3×TTM EPS
Q1 2026 snapshot
Sales
₹8.97K Cr
Operating profit
-
OPM
-
Net profit
₹921 Cr
EPS
₹15.86
Scorecard · 7 axes
Quality
Avg
48/100
Valuation
Good
23.6×
Growth
Avg
+8.3%
Profitability
Avg
10.7%
Performance
Avg
+21.6%
Entry Point
Weak
92%
Red Flags
Strong
0 flags
Shareholding Pattern
51.8%Promoter
Promoter51.8%
FII15.2%
DII25.9%
Public7.1%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue7,978.528,516.937,973.448,406.298,833.548,970.38
Net Profit845.57902.83824.2848.13909.8920.84
NPM %10.6%10.6%10.3%10.1%10.3%10.3%
AlertPre-trade